Moreover, our study examined the relationship between AIMP2 gene expression and common anti-tumor drugs using the CellMiner database, revealing that high AIMP2 expression is predicted to correlate with tolerance to multiple anti-tumor drugs. The gene discussed is AIMP2; the disease is neoplasm.